Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in
the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains …

Biomarkers-guided precision therapeutics has revolutionized the clinical development and
administration of molecular-targeted anticancer agents. Tailored precision cancer therapy …

Macrophages become activated initiating innate immune responses. Depending on the
signals, macrophages obtain an array of activation phenotypes, described by the broad …

Accurate noninvasive tests (NITs) are needed to replace liver biopsy for identifying
advanced fibrosis caused by nonalcoholic steatohepatitis (NASH). We analyzed screening …

Hepatocellular carcinoma (HCC) has become a leading cause of cancer-related death,
making the elucidation of its underlying mechanisms an urgent priority. Inflammation is an …

The PI3K/Akt pathway plays a crucial role in the survival, proliferation, and migration of
macrophages, which may impact the development of atherosclerosis. Changes in Akt …

Hepatocellular carcinoma (HCC) cells are metabolically distinct from normal hepatocytes by
expressing the high-affinity hexokinase (HK2) and suppressing glucokinase (GCK). This is …

With the increasing market demand for high-performance lithium-ion batteries with high-
capacity electrode materials, reducing the irreversible capacity loss in the initial cycle and …

Recent work suggests that cholesterol metabolism impacts innate immune responses
against infection. However, the key enzymes or the natural products and mechanisms …

Hepatocellular carcinoma (HCC) is a deadly form of liver cancer with limited treatment
options. The c‐Myc transcription factor is a pivotal player in hepatocarcinogenesis, but the …